Affinivax
David Rossow is a Board Observer and a Founding Partner of the Strategic Investment Fund at the Bill & Melinda Gates Foundation overseeing program-related investments in global health, global development, global growth and opportunity, and US programs from the foundation’s $2.0 billion allocations. He currently heads the fund’s international work with a focus on biotech in Europe and Israel, and tech-enabled service/product delivery in South Asia and Sub-Saharan Africa. Prior to joining the foundation in 2010, David worked on deal teams in private equity and investment banking, where he was responsible for executing leveraged buyout, equity, debt, restructuring, and merger & acquisition transactions across a variety of industries.
This person is not in the org chart
This person is not in any offices
Affinivax
1 followers
Affinivax is a clinical stage biotechnology company developing a next generation approach in vaccine technologies to design both preventive and therapeutic vaccines that provide broader protection against infectious and other immune mediated diseases.